Related Experiment Video

Updated: Mar 23, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

20.6K

Abdominal aortic calcification in patients with CKD

Mieke J Peeters1, Jan Ajg van den Brand2, Arjan D van Zuilen3

  • 1464 Department of Nephrology, Radboud University Medical Center, PO box 9101, 6500 HB, Nijmegen, The Netherlands. Mieke.Peeters@radboudumc.nl.

Journal of Nephrology
|March 23, 2016
PubMed

Insights

Abdominal aortic calcification (AAC) in chronic kidney disease (CKD) patients predicts cardiovascular events. Identifying AAC in CKD patients can help personalize treatment and improve outcomes.

Area of Science:

  • Nephrology
  • Cardiology
  • Radiology

Background:

  • Abdominal aortic calcification (AAC) is linked to cardiovascular events in dialysis patients and the general population.
  • Limited data exists on AAC's role in non-dialysis chronic kidney disease (CKD) patients.
  • This study investigates the determinants and prognostic value of AAC in non-dialysis CKD patients.

Purpose of the Study:

  • To analyze the determinants of abdominal aortic calcification (AAC) in patients with chronic kidney disease (CKD) not on dialysis.
  • To evaluate the prognostic significance of AAC for cardiovascular events in this patient group.

Main Methods:

  • Utilized data from the MASTERPLAN randomized controlled trial, including a subgroup that underwent X-ray for AAC assessment (2008-2009).
  • Employed a semi-quantitative scoring system for AAC on lateral lumbar X-rays.
  • Analyzed baseline and 2-year data for AAC determinants and used propensity score matching to assess prognostic value against a composite cardiovascular endpoint.

Main Results:

  • Of 280 CKD patients, 50% had moderate or heavy AAC (score ≥4).
  • Independent determinants for AAC score ≥4 included older age, prior cardiovascular disease, higher triglycerides, and higher phosphate levels.
  • An AAC score ≥4 was independently associated with a 5.5-fold increased risk of cardiovascular events (HR 5.5; 95% CI 1.2-24.8).

Conclusions:

  • Abdominal aortic calcification (AAC) assessment can identify chronic kidney disease (CKD) patients at elevated cardiovascular risk.
  • AAC evaluation may inform personalized treatment strategies for CKD patients.
  • Further research is needed to determine if AAC assessment ultimately improves patient outcomes.
Abstract

Keywords:
Abdominal aortic calcificationCardiovascular riskChronic kidney diseasePrognosis

More Related Videos

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro11:30

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

Published on: June 2, 2022

2.6K
A Calcium Phosphate-Induced Mouse Abdominal Aortic Aneurysm Model05:14

A Calcium Phosphate-Induced Mouse Abdominal Aortic Aneurysm Model

Published on: November 18, 2022

4.6K

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.0K
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
779
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
909
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
595
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
459
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
728